LOPID Drug Patent Profile
✉ Email this page to a colleague
When do Lopid patents expire, and what generic alternatives are available?
Lopid is a drug marketed by Pfizer Pharms and is included in one NDA.
The generic ingredient in LOPID is gemfibrozil. Thirty-four suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lopid
A generic version of LOPID was approved as gemfibrozil by CHARTWELL MOLECULES on September 27th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOPID?
- What are the global sales for LOPID?
- What is Average Wholesale Price for LOPID?
Summary for LOPID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Patent Applications: | 4,349 |
Drug Prices: | Drug price information for LOPID |
What excipients (inactive ingredients) are in LOPID? | LOPID excipients list |
DailyMed Link: | LOPID at DailyMed |
Pharmacology for LOPID
Drug Class | Peroxisome Proliferator Receptor alpha Agonist |
Mechanism of Action | Peroxisome Proliferator-activated Receptor alpha Agonists |
US Patents and Regulatory Information for LOPID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer Pharms | LOPID | gemfibrozil | TABLET;ORAL | 018422-003 | Nov 20, 1986 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOPID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Pharms | LOPID | gemfibrozil | CAPSULE;ORAL | 018422-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOPID
See the table below for patents covering LOPID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 148872 | ⤷ Sign Up | |
South Africa | 6905769 | ⤷ Sign Up | |
Brazil | 6911856 | ⤷ Sign Up | |
Germany | 1925423 | ⤷ Sign Up | |
France | 2008997 | ⤷ Sign Up | |
Austria | 291228 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |